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Abstract
Background: By analyzing the clinical features and risk factors in female patients with musculoskeletal symptoms
of Southwest China, this report presents the initial analysis of characteristics in this region and compared with
international evaluative criteria.
Methods: Diagnosis of osteoporosis (OP) was made in female hospital patients age ≥ 18 years admitted from
January 1998 to December 2008 according to WHO definition. Case data were analyzed by symptoms, age, disease
course and risk factors to reveal correlation with diagnosis of OP. Logistic regression was used to identify the risks
of osteoporosis.
Results: A total of 4382 patients were included in the analysis of the baseline characteristics, among which 1455 in
the OP group and 2927 in the non-OP group. The morbidity of OP is significantly increased in females’ ≥ 50 years.
Both groups had symptoms related to pain and numbness; no significant difference was found in reported upper
and lower back pain, or leg pain between two groups (p > 0.05). Neck, shoulder and arm pain, leg and arm
numbness were more common in the non-osteoporosis group (p < 0.05, OR < 1, and upper limit of 95% CI of
OR < 1). Hypertension, diabetes, hyperostosis were major risk factors for the patients with OP. The most common
lifestyle-related risk factors for osteoporosis were smoking, body mass index, lack of physical activity and
menopause.
Conclusions: The present study offers the first reference data of the relationship between epidemiologic
distribution of osteoporosis and associated factors in adults Chinese women. These findings provide a theoretical
basis for its prevention and treatment in developing country.
Background
Osteoporosis (OP) is a general skeletal disease predomi-
nant in aged adults, particularly in postmenopausal
women, characterized by osteopenia and degeneration of
bone microstructure, leading to increasing bone brittle-
ness and tendency for bone fracture [1]. According to
Cochrane systemic reviews, bisphosphonates including
alendronate, etidronate and risedronate are clinically
important and statistically significant reductions in
vertebral fractures for secondary prevention [2-4]. While
no standard therapeutic regimen for primary prevention
is recommended. Early risk factors identification and
early intervention in high-risk groups is important to
prevent osteoporosis and bone fracture. The clinical
symptoms of osteoporosis include pain, decreased body
height, dowager’s hump, bone fracture and respiratory
impairment. The optional method to diagnose osteo-
porosis is by measuring bone mineral density (BMD)
with dual-energy x-ray absorptiometry (DEXA) at the
hip and lumbar spine. DEXA is recommended by the
World Health Organization (WHO) in 1994 as the gold
standard to measure BMD to diagnose asymptomatic
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BMD, 0.6% of young women (those 20-49 years) have
osteoporosis and 16% have osteopenia, while in white
women ≥ 75 years, 38% have osteoporosis and 94% have
osteopenia [5]. The optimal method is the use of clinical
risk factors for fractures together with DXA to diagnosis
and evaluation of patients with osteoporosis in 2002 [6]
At present, The FRAX® tool has been developed by
WHO to evaluate fracture risk of patients [7]. It is
based on individual patient models that integrate the
risks associated with clinical risk factors as well as bone
mineral density (BMD) at the femoral neck. However,
these methods were not widely applied in developing
countries due to lack certain information channel.
Osteoporosis is a recognized major public health pro-
blem in both developed and developing countries. In
China, about 83.9 million people were diagnosed with
osteoporosis in 1997 [8]. As the age span has increased,
osteoporosis has become the fourth most common dis-
ease in aged adults. Due to the high degree of morbidity
and mortality associated with fracture, prevention of
such events is imperative. Because the number of
women at risk for osteoporosis is expected to rise dra-
matically with the aging world population, effective
means to predict more accurately the prevalence of
osteoporosis and related risk factors in communities is
critical [9]. The prevalence in China remains unclear.
Southwest China has a larger population (87 millions)
and has a socioeconomic status that is below the Chi-
nese average. No studies of clinical data of osteoporosis
in this region have been previously reported. Thus, stu-
dies characterizing the epidemiology of osteoporosis and
associated factors in Chinese females are required. To
begin to characterize clinical osteoporosis in this popu-
lation, we performed a retrospective cross-sectional sur-
vey of osteoporosis, including demographic and social
information, musculoskeletal symptoms, medical com-
plications, history of bone fracture, and disease course
and lifestyle factors in female subjects using 10 years of
hospital data.
Methods
Patients
This study was approved by the institutional ethics com-
mittee at Sichuan University and written informed con-
sents were obtained from all subjects prior to
examination. Research carried out in compliance with
the Helsinki Declaration [10]. This retrospective analysis
of consecutively collected data was performed in the
West China Hospital of Sichuan University. The total of
4382 adult women age ≥ 18 years hospitalized in the
Department of Rehabilitation Medicine and the Ortho-
pedics Department for pain or numbness in bones or
joints from January 1998 to December 2008 were
consecutively registered. All these patients were with the
chief complaint of osteoarthralgia and at least one of
these clinical symptoms: 1) neck and shoulder pain; 2)
lumbar and back pain; or 3) extremity pain or numb-
ness. Those who with continued cessation of menstrua-
tion for more than 12 months were recognized as
postmenopausal women, and the rest were categorized
as premenopausal or perimenopausal women. Of these
4382 patients, 3399 were postmenopausal, the mean age
at menopause was 43.5 ± 4.15 years (mean ± SD; range,
39 - 58 years) with a mean duration after menopause of
13.1 months. The data from all cases were recorded
consecutively from 1998 and all data were submitted to
the OP Research Center and the diagnoses were con-
firmed according the findings of DEXA. The diagnosis
of OP in this study was established using WHO cri-
teria,
1 so that osteoporosis was defined as a T-score of
less than -2.5 SD. Osteopenia denoted a T-score of -1 to
-2.5 SD. Exclusive criteria included: 1) diseases which
interfere with bone or calcium metabolism; 2) hepatic
or renal inadequacy; 3) taking medicines which could
interfere with bone or calcium metabolism (such as
estrogen, calcitionin, etc.); 4) limited mobility such that
the patient could not position for the bone density test;
and 5) secondary (i. e. steroids, plasmocytoma, or renal)
osteoporosis.
Questionnaires
Osteoporosis registration forms were filled out for all
the female patients by graduate students majoring in
osteoporosis research who had received standard train-
ing. The graduate students collected the following infor-
mation: demographic information, medical history such
as hypertension, diabetes mellitus, and hyperostosis,
clinical features, physical examination, lifestyle factors,
BMD value (T-Score), complications such as bone frac-
ture. Demographic information including age, menstrual
history, education level, body mass index (BMI)
and home address. Education level was categorized in
three groups, by number of years of schooling: low level
(< 6 years), medium level (6-9 years), and high level (> 9
years). Patients were interviewed about their level of
physical activity classified as never, occasionally (two to
five times a week, more than half an hour every time),
o rf r e q u e n t l y( m o r et h a nf i v et i m e saw e e k ,m o r et h a n
half an hour every time). All the information was con-
firmed by the patients or a reliable relative.
Detailed clinical manifestation included a history of
complaint, the type of symptoms (neck and shoulder
pain; lumbar and back pain; or extremity pain or numb-
ness and number of painful or stiff joints), history of
fracture (hip, spine, wrist, rib, or any site of bone), med-
ical comorbidities (hypertension, diabetes mellitus, and
hyperostosis), the duration of symptoms before
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ings. The database was selectively examined periodically
to ensure the accuracy of the extracted information and
input data.
Bone Mineral Assessment
Bone mineral density at site of lumbar vertebrae (L2-L4)
was measured using the dual emission X-ray absorptio-
metry scanner (FR DMS Corp, Challenger, France) at
the supine lumbar spine, including the posteroanterior
(PA) vertebrae L1-L4, followed by a paired PA/lateral
spine scan of the vertebral bodies of L2-L4; at the left
hip, including the femoral neck and total hip. BMD was
expressed in g/cm
2. The coefficient of variation (CV) of
the technique at our institution was 0.4%, using a phan-
tom measured everyday during the 10-year period of the
current prospective study. We used Asian spine refer-
ence population for young women based on the age
range 20-40 years. T-Scores were calculated using the
standard formula as follows: T-score = BMD of partici-
pant mean-mean BMD of reference population/SD of
BMD of reference population. Cut-off values to categor-
ize individuals as having low bone mass (osteopenia) or
osteoporosis utilized the WHO criteria [1].
Measurements were made by one of two trained and
qualified technicians, and all scans were analyzed by a
single researcher using standardized procedures as out-
lined in the DMS User Manual [11].
Consecutively registered patients to establish an osteo-
porosis database and retrospective observed the clinical
features of osteoporosis and analyzed the factors that
may affect its prognosis.
Data Processing and Statistical Analysis
In the univariate analysis, mean values of age, BMI, T
values and duration of osteoporosis were analyzed as
continuous variables, while frequency of physical activ-
ity, clinical symptoms, history of bone fracture, compli-
cations, smoking and calcium supplements were
analyzed as categorical variables. To examine the base-
line differences of participants by group, we calculated
each group’s means and percentages and performed T-
test or chi-square test to examine baseline differences
by group. According to the WHO’s definition [1],
women patients were classified as osteoporotic if they
had a T score of -2.5. We divided the patients into two
groups according to the above criteria of osteoporosis.
Incidence rates of pain in the neck, shoulder, lower
back, upper back, leg or arm and numbness in one or
more extremities in the osteoporosis group and non-
osteoporosis group were compared. The results for the
whole cohort and subgroups were compared. The choice
of subgroups was based on the phase of menopause at
baseline. The data were analyzed in subgroups for
osteoporosis group according to the following cate-
gories: premenopausal, perimenopausal and postmeno-
pausal women.
The correlation of clinical symptoms, average age,
average course of disease and complications with bone
densities of lumbar vertebrae was also analyzed in osteo-
porosis patients.
Statistical analysis was conducted with SPSS 13.0 soft-
ware (SPSS, Inc., Chicago, IL). Continuous variables were
expressed as mean ± standard deviation (SD); those in a
category were expressed as a frequency (percentage). T-
test was applied to examine the statistical differences
between the two groups. Numerical data were compared
by chi-square. The normal distribution of variables was
confirmed by calculating skew and kurtosis before apply-
ing standard tests. One-way analysis of variance
( A N O V A )w a sa p p l i e dw h e nc o m p a r i n gd i f f e r e n c e so f
groups with a post-hoc test using Tukey’sm e t h o d .O n e -
way ANOVA was used to compare continuous variables
between multiple groups and Chi-squared tests to com-
pare proportions. Factors that may influence prognosis of
osteoporosis including age, course of disease, lifestyle fac-
tors, clinical symptoms, and complications were fitted
into a logistic regression model for multi-variable analy-
sis. A P value of < 0.05 was considered statistically signifi-
cant. Odds ratio (OR) value and 95% Confidence interval
were calculated and tested for significance.
Results
Demographic Variables
All participants completed a structured questionnaire.
Data were collected from the completed checklists and
the patients’ electronic medical records. These data
sources were reviewed and extracted for patient demo-
graphics including current age and age at menarche and
menopause, comorbidity conditions, medication history,
and life style.
A total of 4382 patients were included in the analysis
of the baseline characteristics, among which 1455 in the
OP group and 2927 in the non-OP group. Table 1
shows demographic baseline of the two groups taking
Table 1 Demographic baseline of OP group and non-OP
group
Osteoporosis
group
Non-Osteoporosis
Group
(n = 1455) (n = 2927)
Current age (yrs) 66.5 ± 8.5* 62.4 ± 7.8
Age at menarche (yrs) 12.4 ± 3.5 12.5 ± 4.1
Age at menopause (yrs) 43.3 ± 5.3 45.2 ± 4.7
Current height (m) 1.52 ± 0.21* 1.59 ± 0.25
Current weight (kg) 54.5 ± 5.6 53.6 ± 4.
* Osteoporosis vs. non-osteoporosis, t-test, P < 0.05
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demographic characteristics, except that patients in
osteoporosis group were older (t = 2.355, p = 0.014) and
had a lower height (t = 2.054, p = 0.038) than those in
non- osteoporosis group.
Results from Bmd Measurements
According to osteoporosis is defined as a T-score of less
than -2.5 SD and osteopenia denotes a T-score of -1 to
-2.5 SD, Table 2 shows the results of the DEXA mea-
surements and the proportion of patients who had
osteoporosis, osteopenia and normal BMD at same ske-
letal sites. Of these 4382 women, 33.20% (1455 cases)
had osteoporosis. The corresponding percentages for
osteopenia were 20.45% (896 cases) and 46.35% (2031
cases) were with normal BMD.
Age-stratified analysis showed all of the three groups
had the trend that the T value of BMD reached its peak
at age 30 to 39 years, started to decline at age 40 to 49
years, and declined significantly from age 60 to 69 years.
Analysis revealed that, in the osteopenia and normal
BMD groups, bone density decreased with age reaching
its lowest level at age 60-69, but later this pattern was
not apparent. In the osteoporosis group, among patients
> 40 years, bone density decreased as age increased (Fig-
ure 1). The percentage of osteoporosis in female patients
aged 60-69 years was 38.14%, which took the largest
proportion. Bone density of women > 69 years was sig-
nificantly lower than that of younger patients in all
groups, a statistically significant finding by one-way
ANOVA test (P < 0.05, Table 2).
Clinical Symptoms Associated With Op
Table 3 shows the incidence rates of neck pain, shoulder
pain, lower back pain, upper back pain, leg pain, leg
numbness, arm pain, arm numbness and bone fracture
of osteoporosis and non-osteoporosis groups. Both
groups had symptoms related to pain and numbness; no
significant difference was found in reported upper and
lower back pain, or leg pain between two groups (p >
0.05). Neck, shoulder and arm pain, leg and arm numb-
ness were more common in the non-osteoporosis group
(p < 0.05, OR < 1, and upper limit of 95% CI of OR <
1). However, the incidence of bone fracture was signifi-
cantly higher in osteoporosis group (p <0 . 0 5 ,O R>1 ,
and lower limit of 95% CI of OR > 1).
In the osteoporosis group the most common symp-
toms were lower back pain, leg pain and upper back
pain with incidence rates of 76.91%, 68.93%, 49.69%
respectively, followed by shoulder pain (46.25%), neck
pain (43.92%), arm pain (41.24%), arm numbness
(36.43%), and leg numbness (34.36%). In the group with-
out osteoporosis, the most common symptom was lower
back pain (76.94%), leg pain (70.52%), shoulder pain
(55.11%), neck pain (52.07%), upper back pain (49.37%),
arm pain (47.69%), and leg numbness (37.89%).
According to the menstrual status, the patients of
osteoporosis were sub-divided into three groups: preme-
nopausal (72 cases), perimenopausal (143 cases) and
postmenopausal (1240 cases). Table 4 showed: 1) the
maximum proportions of sites of pain or numbness in
the three sub-groups were 3 sites (36.11%), 5 sites
(30.77%) and 5 sites (30.81%) respectively. The averages
of sites of pain or numbness in the three sub-groups
were 2.80 sites, 3.50 sites and 3.24 sites respectively,
Kruskal-Wallis test manifested that the value of Chi-
square was 11.200, p = 0.004, indicating significant dif-
ferences exited among the three groups. 2) the maxi-
mum proportions of duration of the symptoms in the
three sub-groups were 6-12 months (20.83%), 36-72
months (20.98%) and >144 months (29.35%) respec-
tively. The averages of duration of the symptoms in the
three sub-groups were 36.44 months, 52.95 months and
75.58 months respectively, the value of Chi-square was
17.299, p = 0.000, indicating significant differences
exited among the three groups. 3) the occurrences of
bone fracture (single + multiple) were 6.95%, 39.16%
and 15.57% respectively, the value of Chi-square was
5.067, p = 0.079, indicating there were no significant dif-
ferences exited among the three groups. (Table 4).
Table 2 Age-stratified analyses of case-distributions and BMD measurements
Age (years) Osteoporosis
(n = 1445)
T value
(mean ± SD)
Osteopenia
(n = 896)
T value
(mean ± SD)
Normal BMD
(n = 2031)
T value
(mean ± SD)
# cases % # cases % # cases %
< 30 5 0.34 -2.84 ± 0.22* 10 1.12 -1.27 ± 0.26 13 0.64 0.77 ± 0.26**
30-39 7 0.48 -2.75 ± 0.21* 14 1.56 -1.16 ± 0.46 218 10.73 0.78 ± 0.22**
40-49 59 4.05 -2.86 ± 1.18* 78 8.71 -1.23 ± 0.51 580 28.56 -0.23 ± 0.51**
50-59 475 32.65 -2.94 ± 0.28* 245 27.34 -1.39 ± 0.47 768 37.81 -0.39 ± 0.47**
60-69 555 38.14 -2.97 ± 0.31* 312 34.82 -1.47 ± 0.52 298 14.67 -0.47 ± 0.52**
> 69 354 24.33 -3.04 ± 0.36* 237 26.45 -1.37 ± 0.61 154 7.89 -0.37 ± 0.21**
*comparison of bone density in age groups in osteoporosis group, ANOVA analysis;
**comparison of bone density in age groups in normal BMD group, ANOVA analysis
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Data of associated diseases are reported in Table 5.
Hypertension, diabetes mellitus and hyperostosis were
more frequent in the osteoporosis patients (21.8 vs.
15.1%, X
2 = 30.339, p = 0.000; 9.7 vs.5.9%, X
2 = 21.320,
p = 0.000 and 66.0 vs. 6.4%, X
2 = 1786.041, p = 0.000
respectively, P < 0.05). The OR and 95% CI of them
were 1.566 (1.334-1.839), 1.719 (1.363-2.168) and 28.342
(23.595-34.045) respectively, which indicated that
Hypertension, diabetes mellitus and hyperostosis were
the risk factors of osteoporosis.
The most common lifestyle-related risk factors for
osteoporosis were smoking, body mass index, lack of
physical activity and menopause (Table 5). In osteoporo-
sis group the ratio of current or former smoker was sig-
nificantly higher than that of non-osteoporosis group
(16.1% vs. 4.9%, X
2 = 156.280, p = 0.000, OR = 3.759,
95% CI = (3.019-4.679)), which indicated that smoking
was a risk factor of osteoporosis. The cases whose body
mass index ≥ 25 was more prevalence in osteoporosis
group (44.3% vs. 19.6%, X
2 = 324.746, p = 0.000, OR =
3.441, 95% CI = (2.998-3.949)), which indicated that the
BMI was a risk factor of osteoporosis. In osteoporosis
group the ratio of cases who had frequently physical
activity was lower than that of non-osteoporosis group
(15.9% vs. 29.6%, X
2 = 95.889, p = 0.000, OR = 0.452,
95% CI = (0.385-0.531)), which indicated that physical
activity was a protective factor of osteoporosis. Regard-
ing menopause status, 1240 cases in osteoporosis group
and 2159 cases of non-osteoporosis group were postme-
nopausal (85.2% vs. 73.7%, X
2 = 73.377, p = 0.000, OR =
2.052, 95% CI = (1.737-2.423)), indicating that
Figure 1 the trend of T value changes as age increasing of three groups. Age-stratified analysis showed all of the three groups had the
trend that the T value of BMD reached its peak at age 30 to 39 years, started to decline at age 40 to 49 years, and declined significantly from
age 60 to 69 years.
Table 3 Clinical symptoms in patients with and without osteoporosis
Clinical symptoms Osteoporosis
(n = 1455)
Non-osteoporosis
(n = 2927)
Chi-square value Odds ratio
(OR(95%CI))
P value
# cases % # cases %
neck pain 639 43.92 1524 52.07 25.823* 0.721(0.635-0.818)
Δ 0.000
shoulder pain 673 46.25 1613 55.11 30.528* 0.701(0.618-0.795)
Δ 0.000
lower back pain 1119 76.91 2252 76.94 0.001 0.998(0.860-1.159) 0.981
upper back pain 723 49.69 1445 49.37 0.041 1.013(0.893-1.149) 0.840
leg pain 1003 68.93 2064 70.52 1.157 0.928(0.809-1.064) 0.282
leg numbness 500 34.36 1109 37.89 5.195* 0.858(0.753-0.979)
Δ 0.023
arm pain 600 41.24 1396 47.69 16.336* 0.770(0.678-0.874)
Δ 0.000
arm numbness 530 36.43 1196 40.86 8.007* 0.829(0.728-0.944)
Δ 0.005
bone fracture 254 17.46 120 4.10 222.124* 4.947(3.941-6.210)
Δ 0.000
*Osteoporosis vs. without osteoporosis, X
2-test, P < 0.05
ΔLogistic regression of relationship between osteoporosis and clinical symptoms
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Also, higher educational level and regular calcium sup-
plements were the protective factors of OP (Table 5).
Discussion
This is the first ten-year longitudinal study with regard
to musculoskeletal pain or numbness of patients with
osteoporosis in southwest China. We established the OP
database to evaluate the clinical features of OP in West
China Hospital of Sichuan University, a large hospital
with more than 4000 hospital beds. We discuss the
novel findings comparing with data from the United
States and Europe.
Osteoporosis is predominately found in females. In the
European Vertebral Osteoporosis Study of 15,570 men
and women age 50-79, [9] osteoporosis affected 3% to
6% of men over 50, whereas another study found the
lifetime risk of hip fracture for 50-year-olds in the Uni-
ted Kingdom was 11.4% for women and 3.1% for men
[12,13]. The occurrence of osteoporosis is influenced by
many factors, especially decreasing rates of peak bone
mass and osteopenia after menopause. Current opinion
is that lack of estrogen after menopause and aging are
the main causes of osteoporosis [14].
Epidemiologic studies indicated the incidence of
osteoporosis in females aged 50-59 years is >50% [15]
due to changes in endocrine metabolism. Estrogen levels
significantly decrease after menopause, especially in the
5-10 years immediately following menopause [16].
Women within three years of menopause who lose bone
rapidly are twice as likely to have vertebral and periph-
eral fractures as their normal or slower-bone-losing
counterparts, again similar to BMD predictions [17].
Most cases of osteoporosis occur in postmenopausal
women, and incidence increases with age. Bone density
is an important determinant of fracture risk, especially
in women age ≥ 65 years [18,19]. In the United States,
approximately 20% of white women age ≥ 50 years have
osteoporosis, defined as femoral BMD > 2.5 SD below
the mean of young, healthy white women [5,20].
Another 35-50% have low bone mass, defined as BMD
1-2.5 SD below the mean. Osteoporosis rates vary with
ethnicity, with the highest r a t e si nw h i t e sa n dt h o s eo f
Asian descent and the lowest r a t e si nb l a c k s[ 2 1 ] .O u r
present study also showed that the incidence of osteo-
porosis increased after the age of 50 years, reaching its
peak in patients aged 60-69 years. Therefore prevention
strategies should be aimed at this cohort.
Interestingly, we found that musculoskeletal pain and
numbness are prevalent clinical manifestations among
hospitalised patients on Rehabilitation medicine wards.
Sometimes this group of patients was misdiagnosed as
osteoporosis. As we know, musculoskeletal pain and
numbness may be one of common symptoms of osteo-
porosis, followed by shortness, dowager’s hump, bone
fracture and respiratory disorder. Previous data showed
67% of osteoporosis patients had localized lower back
pain, 9% had lower back pain and extremity radiating
pain, 10% had lower back and girdle pain, 4% had lower
back pain and numbness, 10% had lower back pain,
limb numbness and numbness/weakness in the lumber
[22].
In this study, our data showed there was no correla-
tion between shoulder pain and arm pain and
Table 4 Sub-group analysis of clinical characteristics
related to OP
Osteoporosis group (n = 1455)
Premenopausal Perimenopausal Postmenopausal
(n = 72, %) (n = 143, %) (n = 1240, %)
Sites of pain or numbness
1 site 14 (19.44) 15 (10.50) 193 (15.56)
2 sites 12 (16.67) 23 (16.08) 262 (21.13)
3 sites 26 (36.11) 25 (17.48) 225 (18.15)
4 sites 14 (19.44) 36 (25.17) 178 (14.35)
5 sites 6 (8.33) 44 (30.77) 382 (30.81)
Average
sites
2.80 3.50 3.24
Chi-
square
11.200
P 0.004
Duration of the symptoms
<1
month
5 (6.94) 11 (7.69) 59 (4.76)
1-3
months
9 (12.50) 7 (4.90) 49 (3.95)
3-6
months
8 (11.11) 9 (6.29) 58 (4.68)
6-12
months
15 (20.83) 26 (18.18) 72 (5.81)
12-36
months
12 (16.67) 21 (14.69) 257 (20.73)
36-72
months
11 (15.28) 30 (20.98) 131 (10.56)
72-144
months
5 (6.94) 13 (9.09) 250 (20.16)
> 144
months
7 (9.72) 26 (18.18) 364 (29.35)
Average
months
36.44 52.95 75.58
Chi-
square
17.299
P 0.000
Occurrences of bone fracture
Never 67 (93.06) 87 (60.84) 1047 (84.44)
Single 2 (2.78) 42 (29.37) 70 (5.65)
Multiple 3 (4.17) 14 (9.79) 123 (9.92)
Chi-
square
5.067
P 0.079
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could not support the diagnosis of osteoporosis. Part of
the explanation may be pain was most common symp-
tom of osteoarthritis, rheumatoid arthritis, or other
degenerative joint diseases. Consequently, lower back
pain, leg pain and numbness had no relative specificity
to a diagnosis of osteoporosis, and differential diagnosis
is needed to distinguish osteoporosis from a slipped disc
or muscle strain. Our results showed that musculoskele-
tal pain and numbness had no significant correlation
with osteoporosis, indicating the need for differential
diagnosis to exclude osteoporosis. In addition, severity
of pain or numbness and no correlation with bone den-
sity and number of symptoms did not indicate osteo-
porosis severity. While the occurrence of osteoporosis is
positively correlated with symptoms bone fracture, indi-
cating that bone fracture has the value in diagnosing
osteoporosis. Further, our study showed no correlation
between disease duration and bone density. Bone den-
sity was relatively low among patients only 3-6 months
into the disease. Disease course and patient age should
be considered together when evaluating osteoporosis
severity.
Many studies have shown that better-educated indivi-
duals tend to exercise more, smoke less, and have better
maintenance of body weight. Better educated individuals
also tend to adopt healthier eating habits, including
more dietary calcium, vegetables, soy foods, and fruits
and less saturated fat and alcohol [23-28]. An associa-
tion between higher intakes of calcium, soy, fresh fruits
or vegetables with better bone mass in postmenopausal
women has been reported [25-29]. Such education-asso-
ciated favorable dietary habits might play a role in the
improvement of bone health. In univariate analysis, our
results have demonstrated that that increases in educa-
tional level are associated with lower risks for osteo-
porosis (P > 0.05). It reminds us that we should pay
more attention to the patients’ educational status in
many areas of developing countries.
Clinical data had shown osteoporosis as the main
cause of pathologic fracture in older adults, often lead-
ing to disability and death. The morbidities, distribution
and factors associated with osteoporosis vary by country
and region. The ability to understand its risk factors, at-
risk populations and identification before bone fracture
can greatly aid in osteoporosis prevention and treat-
ment. Traditional epidemiologic studies of osteoporosis
include analysis of bone fracture incidence and preva-
lence, while clinical methods include measuring bone
mass or BMD.
T h ek n o w nr i s kf a c t o ri sah i g h - r i s kp o p u l a t i o nw i t h
no bone fracture but decreased bone mass or BMD. In
general, lower BMD scores indicate more severe osteo-
porosis and higher risk of fracture. A decrease of 1 SD
in BMD represents a 10% to 12% decrease in BMD and
an increase in fracture risk of 1.5 to 2.6 [30,31]. BMD
Table 5 Risk factors associated with OP
Osteoporosis group Non-Osteoporosis Group X
2 p OR (95%)
(n = 1455) (n = 2927)
Postmenopausal (n) 1240 (85.2) * 2159 (73.7) 73.377 0.000 2.052(1.737-2.423)
Body mass index (kg/m
2) 25.6 ± 3.1* 23.4 ± 2.8
< 20 (n) 25(1.7) 91(3.1)
20-25 (n) 786(54.0) 1300(44.4)
≥25 (n) 644(44.3)* 574(19.6) 324.746 0.000 3.441(2.998-3.949)
Education level (n)
Elementary 747(51.3) 1354(46.2)
High school or equivalent 456(31.3) 898(30.7)
College or equivalent 252(17.4) * 675(23.1) 19.208 0.000 0.699(0.595-0.821)
Calcium supplements (n) 699(48.0) * 1897(64.8) 113.186 0.000 0.502(0.442-0.570)
Physical activity (n)
Never 818(56.2) 1724(58.9)
Occasionally 405(27.8) 338(11.5)
Frequently 232(15.9) * 865(29.6) 95.889 0.000 0.452(0.385-0.531)
Smoking status (n)
Current or former smoker 234(16.1) * 142(4.9) 156.280 0.000 3.759(3.019-4.679)
Never smoke 1221(83.9) 2785(95.1)
Hypertension (n) 317(21.8)* 442(15.1) 30.339 0.000 1.566(1.334-1.839)
Diabetes mellitus (n) 141(9.7) * 172(5.9) 21.320 0.000 1.719(1.363-2.168)
Hyperostosis (n) 961(66.0)* 188(6.4) 1786.041 0.000 28.342(23.595-34.045)
*: compared with non-OP group, significant difference exited.
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density is used to predict fracture risk at that site. In
our study, the results from multiple regression analysis
indicate that associated complications including hyper-
tension, diabetes mellitus and hyperostosis are as impor-
tant risk factors of low BMD as the lack of physical
activity, loss of height and smoking. This indicates that
the treatment guidelines should be established in this
region according to risk-related factors.
The development of the FRAX® models for fracture
risk assessment has been based on a programme of
work undertaken at the WHO Collaborating Centre for
Metabolic Bone Diseases at Sheffield University. Clinical
risk factors included age, sex,w e i g h t ,h e i g h t ,p r e v i o u s
fracture, parent fractured hip, current smoking, gluco-
corticoids, rheumatoid arthritis, secondary osteoporosis,
alcohol 3 or more units/day, and Bone mineral density
(BMD). Our study excluded secondary (i. e. steroids,
plasmocytoma, or renal) osteoporosis and focused on
primary osteoporosis. We expected to combine China’s
national conditions compared with the international
level using ten years data to guide the diagnosis and
treatment for OP in worldwide primary hospital.
Furthermore, this study has showed different conclu-
sion from previous study with regard to BMI and osteo-
porosis [32-34]. It has been established that BMI is a
protective factor against osteoporosis, and it is also
included as protective factor in FRAX [35-37]. Based on
the research of this database, we considered BMI was
not a protective factor for OP. Therefore, we infer that
the difference of ethnicity may affect the effect of obe-
sity to female osteoporosis. The updated study reported
that BMD at the spine and hip have significant genetic
determination, BMI is more likely to be affected by
environmental factors than BMD [38]. In addition, BMD
at the spine and hip shares more genetic effect (pleio-
tropy) than BMI and BMD do in Chinese Han ethnicity,
though the effects are significant for both [38]. Previous
study found that the contribution of ADRB3 genotypes
to the prediction of BMI, BMD and fracture risk is lim-
ited in Caucasian population [39]. Thus, several shared
genomic regions for BFM and BMD were identified and
may benefit further positional and functional studies,
aimed at eventually uncovering the complex mechanism
underlying the shared genetic determination of obesity
and osteoporosis [40]. As for Asian anthodium female,
high BMI is not a protective factor for bone mineral
density (BMD), inversely, can be a risk factor. This find-
ing was consistent with previously published work.
Further studies are necessary to clarify this hypothesis.
Conclusions
To the best of our knowledge, the present study offers
the first reference data of the relationship between
epidemiologic distribution of osteoporosis and asso-
ciated factors in adults Chinese women. These reference
data will assist in diagnosis of osteoporosis by DEXA in
Chinese women. DEXA testing is a critical step to
appropriate osteoporosis treatment and fracture preven-
tion. As discussed, better understanding of the clinical
characteristics of patients may lead to improved man-
agement and reduced risk of fracture. Larger investiga-
tions are necessary to understand the prevention and
cure strategies most appropriate for Chinese females. It
calls for vigorous measures to implement public health
education and professional training to provide sustain-
able long-term medical services within the existing
health care infrastructures in this region. The present
study has several limitations. We acknowledge this ret-
rospective study was designed ten years ago and should
advance with the times. Meanwhile, we recognise that a
large prospective cohort study would be required to ver-
ify the current findings.
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